Community-acquired pneumonia related to intracellular pathogens

Catia Cillóniz, Antoni Torres (Lead / Corresponding author), Michael Niederman, Menno van der Eerden, James Chalmers, Tobias Welte, Francesco Blasi

Research output: Contribution to journalArticle

15 Citations (Scopus)
22 Downloads (Pure)

Abstract

Community-acquired pneumonia (CAP) is associated with high rates of morbidity and mortality worldwide; the annual incidence of CAP among adults in Europe has ranged from 1.5 to 1.7 per 1000 population. Intracellular bacteria are common causes of CAP. However, there is considerable variation in the reported incidence between countries and change over time. The intracellular pathogens that are well established as causes of pneumonia are Legionella pneumophila, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, and Coxiella burnetii. Since it is known that antibiotic treatment for severe CAP is empiric and includes coverage of typical and atypical pathogens, microbiological diagnosis bears an important relationship to prognosis of pneumonia. Factors such as adequacy of initial antibiotic or early de-escalation of therapy are important variables associated with outcomes, especially in severe cases. Intracellular pathogens sometimes appear to cause more severe disease with respiratory failure and multisystem dysfunction associated with fatal outcomes. The clinical relevance of intracellular pathogens in severe CAP has not been specifically investigated. We review the prevalence, general characteristics, and outcomes of severe CAP cases caused by intracellular pathogens.

Original languageEnglish
Pages (from-to)1374-1386
Number of pages13
JournalIntensive Care Medicine
Volume42
Issue number9
Early online date8 Jun 2016
DOIs
Publication statusPublished - Sep 2016

Fingerprint

Pneumonia
Chlamydophila psittaci
Coxiella burnetii
Anti-Bacterial Agents
Legionella pneumophila
Chlamydophila pneumoniae
Mycoplasma pneumoniae
Fatal Outcome
Incidence
Respiratory Insufficiency
Morbidity
Bacteria
Mortality
Population

Cite this

Cillóniz, C., Torres, A., Niederman, M., van der Eerden, M., Chalmers, J., Welte, T., & Blasi, F. (2016). Community-acquired pneumonia related to intracellular pathogens. Intensive Care Medicine, 42(9), 1374-1386. https://doi.org/10.1007/s00134-016-4394-4
Cillóniz, Catia ; Torres, Antoni ; Niederman, Michael ; van der Eerden, Menno ; Chalmers, James ; Welte, Tobias ; Blasi, Francesco. / Community-acquired pneumonia related to intracellular pathogens. In: Intensive Care Medicine. 2016 ; Vol. 42, No. 9. pp. 1374-1386.
@article{96dfe225391446c799e20110259611fe,
title = "Community-acquired pneumonia related to intracellular pathogens",
abstract = "Community-acquired pneumonia (CAP) is associated with high rates of morbidity and mortality worldwide; the annual incidence of CAP among adults in Europe has ranged from 1.5 to 1.7 per 1000 population. Intracellular bacteria are common causes of CAP. However, there is considerable variation in the reported incidence between countries and change over time. The intracellular pathogens that are well established as causes of pneumonia are Legionella pneumophila, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, and Coxiella burnetii. Since it is known that antibiotic treatment for severe CAP is empiric and includes coverage of typical and atypical pathogens, microbiological diagnosis bears an important relationship to prognosis of pneumonia. Factors such as adequacy of initial antibiotic or early de-escalation of therapy are important variables associated with outcomes, especially in severe cases. Intracellular pathogens sometimes appear to cause more severe disease with respiratory failure and multisystem dysfunction associated with fatal outcomes. The clinical relevance of intracellular pathogens in severe CAP has not been specifically investigated. We review the prevalence, general characteristics, and outcomes of severe CAP cases caused by intracellular pathogens.",
author = "Catia Cill{\'o}niz and Antoni Torres and Michael Niederman and {van der Eerden}, Menno and James Chalmers and Tobias Welte and Francesco Blasi",
year = "2016",
month = "9",
doi = "10.1007/s00134-016-4394-4",
language = "English",
volume = "42",
pages = "1374--1386",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",
number = "9",

}

Cillóniz, C, Torres, A, Niederman, M, van der Eerden, M, Chalmers, J, Welte, T & Blasi, F 2016, 'Community-acquired pneumonia related to intracellular pathogens', Intensive Care Medicine, vol. 42, no. 9, pp. 1374-1386. https://doi.org/10.1007/s00134-016-4394-4

Community-acquired pneumonia related to intracellular pathogens. / Cillóniz, Catia; Torres, Antoni (Lead / Corresponding author); Niederman, Michael; van der Eerden, Menno; Chalmers, James; Welte, Tobias; Blasi, Francesco.

In: Intensive Care Medicine, Vol. 42, No. 9, 09.2016, p. 1374-1386.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Community-acquired pneumonia related to intracellular pathogens

AU - Cillóniz, Catia

AU - Torres, Antoni

AU - Niederman, Michael

AU - van der Eerden, Menno

AU - Chalmers, James

AU - Welte, Tobias

AU - Blasi, Francesco

PY - 2016/9

Y1 - 2016/9

N2 - Community-acquired pneumonia (CAP) is associated with high rates of morbidity and mortality worldwide; the annual incidence of CAP among adults in Europe has ranged from 1.5 to 1.7 per 1000 population. Intracellular bacteria are common causes of CAP. However, there is considerable variation in the reported incidence between countries and change over time. The intracellular pathogens that are well established as causes of pneumonia are Legionella pneumophila, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, and Coxiella burnetii. Since it is known that antibiotic treatment for severe CAP is empiric and includes coverage of typical and atypical pathogens, microbiological diagnosis bears an important relationship to prognosis of pneumonia. Factors such as adequacy of initial antibiotic or early de-escalation of therapy are important variables associated with outcomes, especially in severe cases. Intracellular pathogens sometimes appear to cause more severe disease with respiratory failure and multisystem dysfunction associated with fatal outcomes. The clinical relevance of intracellular pathogens in severe CAP has not been specifically investigated. We review the prevalence, general characteristics, and outcomes of severe CAP cases caused by intracellular pathogens.

AB - Community-acquired pneumonia (CAP) is associated with high rates of morbidity and mortality worldwide; the annual incidence of CAP among adults in Europe has ranged from 1.5 to 1.7 per 1000 population. Intracellular bacteria are common causes of CAP. However, there is considerable variation in the reported incidence between countries and change over time. The intracellular pathogens that are well established as causes of pneumonia are Legionella pneumophila, Mycoplasma pneumoniae, Chlamydophila pneumoniae, Chlamydophila psittaci, and Coxiella burnetii. Since it is known that antibiotic treatment for severe CAP is empiric and includes coverage of typical and atypical pathogens, microbiological diagnosis bears an important relationship to prognosis of pneumonia. Factors such as adequacy of initial antibiotic or early de-escalation of therapy are important variables associated with outcomes, especially in severe cases. Intracellular pathogens sometimes appear to cause more severe disease with respiratory failure and multisystem dysfunction associated with fatal outcomes. The clinical relevance of intracellular pathogens in severe CAP has not been specifically investigated. We review the prevalence, general characteristics, and outcomes of severe CAP cases caused by intracellular pathogens.

U2 - 10.1007/s00134-016-4394-4

DO - 10.1007/s00134-016-4394-4

M3 - Article

VL - 42

SP - 1374

EP - 1386

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 9

ER -

Cillóniz C, Torres A, Niederman M, van der Eerden M, Chalmers J, Welte T et al. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Medicine. 2016 Sep;42(9):1374-1386. https://doi.org/10.1007/s00134-016-4394-4